Association Between Specific Type 2 Diabetes Therapies and Risk of Alzheimer’s Disease and Related Dementias in Propensity-Score Matched Type 2 Diabetic Patients

por Torrandell-Haro, Georgina, Branigan, Gregory L., Brinton, Roberta Diaz, Rodgers, Kathleen E.
Publicado 2022

Age and sex differences on anti-hyperglycemic medication exposure and risk of newly diagnosed multiple sclerosis in propensity score matched type 2 diabetics

por Branigan, Gregory L., Torrandell-Haro, Georgina, Vitali, Francesca, Brinton, Roberta Diaz, Rodgers, Kathleen
Publicado 2022

Statin therapy and risk of Alzheimer's and age‐related neurodegenerative diseases

por Torrandell‐Haro, Georgina, Branigan, Gregory L., Vitali, Francesca, Geifman, Nophar, Zissimopoulos, Julie M., Brinton, Roberta Diaz
Publicado 2020

Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer

por Branigan, Gregory L., Torrandell‐Haro, Georgina, Soto, Maira, Gelmann, Edward P., Vitali, Francesca, Rodgers, Kathleen E., Brinton, Roberta Diaz
Publicado 2022

Breast cancer therapies reduce risk of Alzheimer’s disease and promote estrogenic pathways and action in brain

por Branigan, Gregory L., Torrandell-Haro, Georgina, Chen, Shuhua, Shang, Yuan, Perez-Miller, Samantha, Mao, Zisu, Padilla-Rodriguez, Marco, Cortes-Flores, Helena, Vitali, Francesca, Brinton, Roberta Diaz
Publicado 2023